Delivery Order SPE2DB24D1205-SPE2DB25FCURP

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $8.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $23,016.42 firm-fixed-price delivery order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,791.12, is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR ML, a specialty medication. The contract has a firm fixed-price pricing structure and an ultimate completion date of October 11, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,366.55 Firm Fixed Price Delivery Order contract is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, with an ultimate completion date of October 25, 2024. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,292.36 Firm Fixed Price Delivery Order (SPE2DB22D2211) is for the supply of BIMZELX 160 MG/ML AUTOINJECTOR, a specialty medication, with a completion date of January 16, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $36,199.65 and is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML medical products. The contract is a firm fixed-price delivery order, with a period of performance running through February 10, 2025. AmerisourceBergen is the prime contractor on...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,108.93, is for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty medication. The contract has a completion date of July 29, 2024 and is a Firm Fixed Price contract. There is no set-aside designation indicated for this award. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the delivery of BIMZELX 160 MG/ML AUTOINJECTORML medical supplies. The contract has a ceiling value of $49,184.69 and an ultimate completion date of September 13, 2024. It is a Firm Fixed Price Delivery Order contract with no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $61,765.98, is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a specialty pharmaceutical product. The contract has a firm-fixed price pricing type and an ultimate completion date of July 3, 2024. The contract is not designated with any set-aside requirements, indicating open...
The federal contract award is for the delivery of BIMZELX 160 MG/ML AUTOINJECTOR medication to the Defense Logistics Agency (DLA), a defense agency. The contract, worth $9,982.88, is a Firm Fixed Price Delivery Order with AmerisourceBergen Drug Corp as the prime contractor. The contract has an ultimate completion date of November 13, 2024 and was awarded on November 12, 2024. The place of performance is Conshohocken, PA. This contract award is part of a larger Indefinite Delivery Contract...
This federal contract award, with an ID of SPE2DB20D2104|SPE2DB25FMGVG, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,802.33 firm-fixed-price delivery order covers the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product, to support federal healthcare programs. The contract is not designated as a set-aside and serves as a delivery order under AmerisourceBergen's existing...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB25FCURP
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,632.69 Firm Fixed Price Delivery Order is for the supply of BIMZELX 160 MG/ML AUTOINJECTORML, a medical product. The contract has an ultimate completion date of March 7, 2025.

This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 6/5/25, 10:25 AM